ELECTRONIC CAPTURE OF CANCER CLAIMS DATA FOR THE SEER PROGRAM

法律要求所有50个州的医疗保健提供者向州癌症登记机构报告新的癌症病例。国家癌症研究所(NCI)的监测、流行病学和最终结果(SEER)计划收集每个项目的数据 而SEER的每个癌症患者都覆盖了这些地区。这些数据包括人口统计数据、癌症描述、有限的初步治疗信息，以及包括已故患者死亡原因在内的患者随访。过去，登记数据的主要来源是医院。随着癌症护理和递送系统的日益复杂，越来越多的患者在医生办公室接受专门治疗。因此，对于SEER来说，继续捕获所有癌症病例 他们的治疗信息SEER有兴趣获得其他数据来源，如来自肿瘤学实践的索赔数据。肿瘤学实践声称，事实证明，这是关于详细的系统治疗的丰富信息来源，包括 制剂、剂量、给药日期等。

Healthcare providers in all 50 states are required by law to report new cases of cancer to their state’s cancer registries. The National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) Program, collects data on each and every cancer patient in SEER covered areas. This data includes demographics, a description of their cancer, limited initial treatment information, and patient follow-up including cause of death for deceased patients. In the past the main source of registry data came from Hospitals. With the increasing complexity of cancer care and delivery systems, patients are being increasingly treated exclusively at physicians’ offices. Thus, for SEER to continue capturing all cancer cases and their treatment information SEER is interested in obtaining other sources of data such as claims data from oncology practices. Oncology practice claims has proven to be a rich source of information on detailed systemic therapy, including agents, doses administration dates etc.